Article Details
Retrieved on: 2025-02-13 17:36:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“ANDEMBRY, CSL's first approved recombinant monoclonal antibody discovered and developed entirely by CSL, underscores our more than 40-year legacy in ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here